PRLD
#3011
Prelude Therapeutics Incorporated - Common Stock
5.4 7 USD
-0.14%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-13.72%
Monthly Change
+16.14%
6 month change
+104.10%
Year Change
+355.83%
Previous Close
6.3 4
Open
5.4 7
Low
5.4 7
High
5.4 7
Volume
62
Financials
- Market Capitalization 436.53 M
- Employee 79
- Founded 2016
- CEO N/A
- Website www.preludetx.com
- Headquarter Delaware, United States
- FIGI BBG00K7JY2Q6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.25
Price to sales ratio
18.38
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2984 |  OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -3.65% | -6.38% | +8.20% | +30.69% | 447.63 M USD | ||
| 2988 |  RZLT Rezolute, Inc. - Common Stock | 4.62 USD | -7.23% | -8.15% | -2.12% | -35.11% | 444.87 M USD | ||
| 3020 |  CMPX Compass Therapeutics, Inc. - Common Stock | 2.40 USD | -4.76% | -0.41% | +24.35% | -30.43% | 432.21 M USD | ||
| 3021 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 15.19 USD | -6.06% | +14.64% | +161.90% | -10.65% | 431.75 M USD |
Frequently asked questions about Prelude Therapeutics Incorporated
What is the Prelude Therapeutics Incorporated stock price today?
The current price of Prelude Therapeutics Incorporated (PRLD) is 5.47. Over the past 24 hours, the stock has changed by -13.72%. Follow the PRLD chart for real-time price dynamics.
What is the stock ticker of Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated trades under the ticker PRLD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Prelude Therapeutics Incorporated stock going up?
PRLD has changed by -17.50% over the last week, +16.14% over the last month, and +355.83% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated currently has a market capitalization of 436.53 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Prelude Therapeutics Incorporated earnings last quarter?
Last quarter, Prelude Therapeutics Incorporated reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Prelude Therapeutics Incorporated revenue for the last quarter?
Prelude Therapeutics Incorporated reported quarterly revenue of 5.7 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Prelude Therapeutics Incorporated net income for the last quarter?
Prelude Therapeutics Incorporated reported net income of -13.92 M for the last quarter. The previous quarter showed -10.38 M, which means net income changed by -34.05%.
How many employees does Prelude Therapeutics Incorporated have?
As of the latest available data, Prelude Therapeutics Incorporated has 79 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Prelude Therapeutics Incorporated stock?
You can buy Prelude Therapeutics Incorporated (PRLD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Prelude Therapeutics Incorporated stock?
Investing in Prelude Therapeutics Incorporated requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRLD chart and related analysis on metatrader.com as part of your research.